Crack cocaine and schizophrenia as risk factors for PPD reactivity in the dually diagnosed

Journal of Addictive Diseases

Volumn 17, Issue 3, 1998, Pages 63-74

  Taubes, Tanaquil ^a   Galanter, Marc ^a   Dermatis, Helen ^a   Westreich, Lawrence ^a  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COCAINE; TUBERCULIN;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HOSPITAL PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; PSYCHOSIS; PUBLIC HEALTH; RISK FACTOR; SCHIZOPHRENIA; SCREENING TEST; STATISTICAL ANALYSIS; SUBSTANCE ABUSE; TUBERCULOSIS;

ADOLESCENT; ADULT; COCAINE-RELATED DISORDERS; COMORBIDITY; CRACK COCAINE; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MIDDLE AGED; NEW YORK CITY; RISK; RISK FACTORS; SCHIZOPHRENIA; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY; URBAN POPULATION;

EID: 0031729070     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1300/J069v17n03_06     Document Type: Article

References (36)

1. MacGregor RR, Dunbar D, Graziani AL. Tuberculin reactions among at-tendees at a methadone clinic: relation to infection with the human immunodeficiency virus. Clin Inf Dis. 1994;19:1100–4.
2. Friedman LN, Sullivan GM, Bevilaqua RP, Loscos R. Tuberculosis screening in alcoholics and drug addicts. Am Rev Respir Dis. 1987;136:1188–92.
3. Reichman LB, Felton CP, Edsall JR. Drug dependence, a possible new risk factor for tuberculosis disease. Arch Intern Med. 1979;139:337–9.
4. Perlman DC, Salomon N, Perkins MP, Yancovitz S, Paone D, Des Jarlais DC. Tuberculosis in drug users. Clin Inf Dis. 1995;21:1253–64.
5. Brudney K, Dobkin J. Resurgent tuberculosis in New York City: human immunodeficiency virus, homelessness, and the decline of tuberculosis control programs. Am Rev Respir Dis. 1991;144:745–49.
6. Zolopa AR, Hahn JA, Gorter R, Miranda J, Wlodarczyk D, Peterson J, Pilote L, Moss A. HIV and tuberculosis infection in San Francisco’s homeless adults: prevalence and risk factors in a representative sample. JAMA. 1994; 272:455–61.
7. Prevention and control of tuberculosis among homeless persons: recom-mendations of the advisory council for the elimination of tuberculosis. MMWR. 1992;41-RR-5:13–23.
8. Graham NMH, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, Astemborski J, Vlahov D. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992; 267:369–73.
9. Cayla, JA Garcia de Olalla P, Galdos-Tanguis H, Vidal R, Lopez-Colomes JLI, Gatel JM, Jansa JM. The influence of intravenous drug use and HIV infection in the transmission of tuberculosis. AIDS. 1996;10:95–100.
10. Selwin PA, Hartel D, Lewis VA, Schoenbaum EE, Vermund SH, Klein RS, Walker AT, Friedland GH. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Engl J Med. 1989;320:545–50.
11. Milne RC. Alcoholism and tuberculosis in Victoria. Med J Aust. 1970;2: 955–60.
12. Olin JS, Grzybowski S. Tuberculosis and alcoholism. Canad Med Ass J. 1966;94:999–1001.
13. Hudolin V. Tuberculosis and alcoholism. Ann NY Acad Sci. 1975;252: 353–64.
14. Reichman LB, O’Day R. Tuberculous infection in a large urban population. Amer Rev Respir Dis. 1978;117:705–12.
15. Crack cocaine use among persons with tuberculosis-Contra Costa Country, California, 1987–1990. MMWR. 1991;40(29):485–8.
16. Leonhardt KK, Gentile F, Gilbert BP, Aiken M. A cluster of tuberculosis among crack house contacts in San Mateo County, California. Am J Public Health. 1994;84:1834–6.
17. Herrman HE, Baldwin JA, Christie D. A record-linkage study of mortality and general hospital discharge in patients diagnosed as schizophrenic. Psychological Medicine. 1983;13:581–93.
18. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psych. 1991;36:239–45.
19. Buda M, Tsuang MT, Fleming JA. Causes of death in DSM-III schizo-phrenics and other psychotics (atypical group): a comparison with the general population. Arch Gen Psychiatry. 1988;45:283–5.
20. Casadebaig F, Quemada N. Mortality in psychiatric inpatients. Acta Psy-chiatrScand. 1989;79:257–64.
21. Black DW, Fisher R. Mortality in DSM-IIIR schizophrenia. Schizophrenia Research. 1992;7:109–116.
22. Sims A. Why the excess mortality from psychiatric illness. Brit Med J. 1987;294:986–7.
23. Hewer W, Roessler W, Faetkenheuer B, Loeffler W. Mortality among patients in psychiatric hospitals in Germany. Acta Psychiatr Scand. 1995;91:174–9.
24. Felker B, Yazel JJ, Short D. Mortality and medical comorbidity among psychiatric patients: a review. Psych Serv. 1996;47:1356–63.
25. Buskin SE, Gale JL, Weiss NS, Nolan CM. Tuberculosis risk factors in adults in King County, Washington, 1988 through 1990. Am J Public Health. 1994;84:1750–6.
26. Brown LS, Felton CP. Drug abuse, HIV infection, and tuberculosis. JAMA. 1989;262(5):615–6.
27. Martin RL, Cloninger R, Guze SB, Clayton PJ. Mortality in a follow-up of 500 psychiatric outpatients. Arch Gen Psychiatry. 1985;42:47–54.
28. Ballew KA, Becker DM. Tuberculosis screening in adults who have received bacille Calmette-Guerin vaccine. South Med J. 1995;88(10):1025–30.
29. Sacks MH, Silberstein C, Weiler P, Perry S. HIV-Related risk factors in acute psychiatric inpatients. Hosp Comm Psych. 1990;41(4):449–51.
30. Barclay DM III, Richardson JP, Fredman L. Tuberculosis in the homeless. Arch Fam Med. 1995;4:541–6.
31. Adams HG, Jordan C. Infections in the alcoholic. Med Clin N Amer. 1984;68(1):179–200.
32. Huebner RE, Schein MF, Bass JB. The tuberculin skin test. Clin Inf Dis. 1993;17:968–75.
33. Landesman SH. Commentary: tuberculosis in New York City -the conse-quences and lessons of failure. Am J Public Health. 1993;83:766–8.
34. Lerner BH. New York City’s tuberculosis control efforts: the historical lim-itations of the “war on consumption.” Am J Public Health. 1993;83:758–66.
35. Iseman MD, Cohn DL, Sbrbaro JA. Directly observed treatment of tuber-culosis: we can’t afford not to try it. N Eng J Med. 1993;328(8):576–8.
36. Nazar-Stewart V, Nolan C. Results of a directly observed intermittent iso-niazid preventive therapy program in a shelter for homeless men. Am Rev Respir Dis. 1992;146:57–60.